- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Fingerpaint Group Acquires The MYND Group, Bolstering Market Access Capabilities
Fingerpaint Group, a collective of healthcare companies providing commercialization solutions, is expanding its market access capabilities with the acquisition of The MYND Group, a strategic market access marketing company specializing in pharmaceuticals and biologics.
The MYND Group will enhance Fingerpaint's market access strategy, research, and launch experience. Jonathan Magid will continue leading The MYND Group as Managing Director, reporting to Brannon Cashion, President of Specialty Services at Fingerpaint Group.
Fingerpaint Group has seen significant growth since partnering with private equity firm Knox Lane in 2020.
Reference: Fingerpaint Group Acquires The MYND Group, Bolstering Its Robust Market Access Capabilities. April 4, 2023 / Fingerpaint
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.
Beyond the Scrubs: Understanding Healthcare Providers as People for Increased Engagement
March 28th 2024The benefits of adopting a humanized approach to healthcare provider marketing extend across the healthcare spectrum, enhancing engagement rates, brand loyalty, and marketing ROI, while also driving better outcomes for patients.
